• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Thursday, June 12, 2025
  • Login
  • Register
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Exclusive Interview

Manoj Gopalkrishnan- CEO and Founder of Algorithmic Biologics on reinventing molecular testing by bringing intelligence to molecules

by Rohan Mathawan
June 24, 2022
in Exclusive Interview, Tech
Reading Time: 4 mins read
0
Manoj Gopalkrishnan- CEO and Founder of Algorithmic Biologics

Manoj Gopalkrishnan- CEO and Founder of Algorithmic Biologics

TwitterWhatsappLinkedin
Manoj Gopalkrishnan- CEO and Founder of Algorithmic Biologics
Manoj Gopalkrishnan- CEO and Founder of Algorithmic Biologics

Kindly brief us about the company, its specialization, and the services that your company offers.

Algorithmic Biologics is a deep tech platform technology company. Our product Tapestry is a molecular search solution that applies techniques from AI on genomic data using our patented and proprietary approach. There are many applications that can be built on top of molecular search, ranging from screening for infectious diseases to gene mutations to identifying proteins with desired traits etc. We provide customized solution to our enterprise customers based on the specific application that is of interest to them. We also provide training to clinicians to use our software, report generation services, and necessary technical support on an ongoing basis.

You might also like

GM Accelerates to #2 in U.S. EV Sales with Record Growth and Expanding Portfolio

BMW 5 Series Races Ahead of Mercedes-Benz E-Class in 2025 Luxury Sedan Showdown

Federal Predator Drone Spotted Monitoring Protesters in Los Angeles, Reports Say in Los Angeles Spark Growing Concerns

Who are some of the top industries/sectors adopting molecular testing analysis?

Molecular Testing is a $62 Billion horizontal business that services multiple verticals including Industrial Microbiology & Pharmaceuticals, Food Safety, and Molecular Diagnostics. A significant and most rapidly growing segment of this market is software for scale multiplication that reduces the complexity, effort, and cost of genomic testing. In the future, we will see molecular information driving decision-making for many industries, and the demand for molecular technologies increase rapidly. This will be driven by data science and by more affordable, and more accurate testing. We believe that molecular technology will reinvent healthcare, food, and pharma, but it won’t stop there. It will also reinvent chemicals, textiles, energy, and climate.

Do share some updates on your client base and the work you have been doing lately?

Our key customers are diagnostic and industrial labs, genomic core facilities and service providers who benefit from increasing either throughput or volumes without incurring any additional capital investment. We provide them “scale multiplication” on their installed capacity through our software-only solution. Traditionally such scale multiplication is offered through automation hardware, novel chemistry, and biologics, or algorithm-based efficiencies supported by the software. We are in the third category, which has the advantages of being low capital cost and easy solution delivery through the cloud. The uniqueness of our solution lies in us being an AI-enabled SaaS solution that is independent of the underlying molecular test. This space is greenfield and ripe for a huge growth spurt like we have seen in AI-based medical imaging in the last five years.

What is the technology stack involved in the analysis?

We do modelling of the underlying molecular assays based on fundamental science and convert these models to software. We use these models to drive our inference engines and decision-making. The whole solution is hosted on the cloud and delivered via our web app.

Can you please elaborate on your business strategy and growth plans? Where do you see your company in the coming years?

We want to reinvent molecular testing by bringing intelligence to molecules. We are making accurate molecular testing available at scale. In the coming years, Algorithmic Biologics will bring the power of molecular information to the lives of billions of people. We have an R&D pipeline to innovate and take the innovations to industrial applications. This includes running joint pilots with industry leaders to prove commercial benefits to customers. We often work with channel partners to scale up the product while we stay engaged for customer success.

What do you think will be the driving factors behind the adoption of the molecular testing market?

The increasing prevalence of diseases leading to severe infectious diseases is fueling the growth of the molecular diagnostics market. Also, factors such as the move towards wellness and the rise in demand for personalized care based on genomic analysis are expected to augment the market. The strong growth of molecular diagnostics can also be attributed to the government’s focus on healthcare investments, enhancing the biotechnology sector, and increasing the number of biotechnology companies in the country.

How has the adoption of molecular technology in India/US evolved over the last few years?

Covid played a major role in increasing the installed base, expertise and awareness about molecular and genomic testing. The availability of PCR testing kits more than doubled and the same can now be leveraged for other infectious diseases. The genomic testing cost has continued to come down and is now being used for mainstream applications at an increasing pace. We believe our innovation allows for genomic testing to be more versatile as well as affordable.

How can your business model impact Indian society, lives, and communities?

High price of genomic and molecular testing has long prevented life savings tests from being universally available. In industries, lack of sufficient testing has led to poor standards of quality assurance. By ensuring we use software-based methods on top of gold-standard tests to make them affordable, we can increase the adoption of molecular and genomic testing which can translate into reducing mortality and morbidity in case of healthcare and availability of better quality products in case of products we consume, including food. In the research context, it also means accelerating the innovation without being bottlenecked by budget constraints since discovery assays feed the life science innovation pipeline but need to use cutting-edge technologies that are prohibitively expensive. We allow genomic and molecular testing to be used at scale across sectors without breaking the bank.

Tweet54SendShare15
Previous Post

EV Charging Start-up Statiq Receives $25.7M Investment

Next Post

Netflix lays off 300 employees in cost-cutting drive

Rohan Mathawan

Content Editor at Techstory Media | Technology | Gadgets | Written more than 5000+ articles about different niches from Tech to online real money gaming for reputed brands and companies. Get in touch Email: [email protected] For Business Enquires related to TechStory [email protected]

Recommended For You

GM Accelerates to #2 in U.S. EV Sales with Record Growth and Expanding Portfolio

by Samir Gautam
June 11, 2025
0
GM Accelerates to #2 in U.S. EV Sales with Record Growth and Expanding Portfolio

General Motors (GM) is surging ahead in the electric vehicle (EV) race, securing the #2 spot in the U.S. EV market with over 62,000 EVs sold through May...

Read more

BMW 5 Series Races Ahead of Mercedes-Benz E-Class in 2025 Luxury Sedan Showdown

by Samir Gautam
June 11, 2025
0
BMW 5 Series Races Ahead of Mercedes-Benz E-Class in 2025 Luxury Sedan Showdown

In the ongoing battle of the luxury sedans, BMW appears to have pulled significantly ahead of its archrival, Mercedes-Benz. Just a year after both brands unveiled their next-generation...

Read more

Federal Predator Drone Spotted Monitoring Protesters in Los Angeles, Reports Say in Los Angeles Spark Growing Concerns

by Harikrishnan A
June 11, 2025
0
Federal Predator Drone Spotted Monitoring Protesters in Los Angeles, Reports Say in Los Angeles Spark Growing Concerns

A heightened federal response to recent protests in Los Angeles has alarmed civil liberties advocates and raised new concerns about government overreach. The situation escalated over the weekend...

Read more
Next Post
Netflix logo depicted on a screen with a remote in front

Netflix lays off 300 employees in cost-cutting drive

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook flipkart funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?